trending Market Intelligence /marketintelligence/en/news-insights/trending/xmnvjjpfh4l22oisj9lxvq2 content esgSubNav
In This List

Vaxil appoints CEO

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


Vaxil appoints CEO

Israel-based Vaxil Bio Ltd. appointed David Goren CEO and board member.

Goren previously held senior positions at drugmakers Pfizer Inc. and AstraZeneca PLC.

Vaxil develops and sells immunotherapies for cancer and other diseases in Israel.